[1]周 笳,董丽霞.阿替普酶联合华法林治疗慢阻肺合并肺栓塞的有效性分析[J].医学信息,2019,32(05):146-147.[doi:10.3969/j.issn.1006-1959.2019.05.046]
　ZHOU Jia,DONG Li-xia.Efficacy Analysis of Alteplase Combined with Warfarin in the Treatment of Chronic Obstructive Pulmonary Disease with Pulmonary Embolism[J].Medical Information,2019,32(05):146-147.[doi:10.3969/j.issn.1006-1959.2019.05.046]
点击复制

阿替普酶联合华法林治疗慢阻肺合并肺栓塞的有效性分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年05期
页码:
146-147
栏目:
药物与临床
出版日期:
2019-03-01

文章信息/Info

Title:
Efficacy Analysis of Alteplase Combined with Warfarin in the Treatment of Chronic Obstructive Pulmonary Disease with Pulmonary Embolism
文章编号:
1006-1959（2019）05-0146-02
作者:
周 笳1; 董丽霞2
（1.天津医科大学，天津 300070；2.天津医科大学总医院，天津 300050）
Author(s):
ZHOU Jia1; DONG Li-xia2
(1.Tianjin Medical University,Tianjin 300070,China;2.Tianjin Medical University General Hospital,Tianjin 300050,China)
关键词:
阿替普酶; 华法林; 慢阻肺; 肺栓塞
Keywords:
Alteplase; Warfarin; Chronic obstructive pulmonary disease; Pulmonary embolism
分类号:
R563.3
DOI:
10.3969/j.issn.1006-1959.2019.05.046
文献标志码:
A
摘要:
目的 分析阿替普酶联合华法林治疗慢阻肺（COPD）合并肺栓塞的有效性。方法 回顾分析2017年10月~2018年10月在我院诊治的90例慢阻肺合并肺栓塞患者临床资料，将其随机分为对照组和观察组，各45例，对照组采用肝素联合华法林治疗，观察组采用阿替普酶联合华法林治疗，对比两组临床治疗有效率、凝血功能指标（PT、APTT、TT、Fbg）、动脉血PO2、PCO2、血清心肌肌钙蛋白Ⅰ( cTnⅠ)以及不良反应。结果 观察组治疗总有效率（95.55%）与对照组（91.11%）对比，差异有统计学意义（P＜0.05）；治疗后两组患者PT、APTT、TT 较治疗前降低，Fbg升高，组间比较差异有统计学意义（P＜0.05）；治疗后两组动脉血PO2升高，动脉血PCO2、cTnⅠ降低，与治疗前对比，组间对比差异有统计学意义（P＜0.05）；两组均未发生明显不良反应。结论 阿替普酶联合华法林治疗COPD合并肺栓塞具有良好的有效性，且用药安全，同时在改善心肌损伤方面具有良好的效果。
Abstract:
Objective To analyze the efficacy of alteplase combined with warfarin in the treatment of chronic obstructive pulmonary disease with pulmonary embolism. Methods The clinical data of 90 patients with chronic obstructive pulmonary disease complicated with pulmonary embolism diagnosed and treated in our hospital from October 2017 to October 2018 were retrospectively analyzed. They were randomly divided into two groups: control group (n=45) and group (n=45). The control group was treated with heparin combined with warfarin. The patients in the observation group were treated with ateptidase combined with warfarin. The effective rate, coagulation function index (PT,APTT,TT,Fbg),Arterial blood PO2,PCO2, serum cardiac troponin I (cTnI) and adverse reactions. Results The total effective rate of treatment in the observation group was 95.55% compared with 91.11% in the control group,the difference was statistically significant (P<0.05). After treatment, the PT, APTT and TT of the two groups were lower than before treatment and the Fbg was increased,the difference between the groups, the difference was statistically significant (P<0.05); after treatment, the arterial blood PO2 increased, arterial blood PCO2, cTnI decreased, compared with the pre-treatment, the difference between the groups was statistically significant (P<0.05); no significant adverse reactions occurred in either group. Conclusion Alteplase combined with warfarin is effective in the treatment of COPD with pulmonary embolism and is safe to use. At the same time, it has a good effect in improving myocardial damage.

参考文献/References:


[1]陈振华,丘新才,林淑芳,等.阿替普酶联合华法林治疗慢性阻塞性肺疾病合并肺栓塞的效果观察[J].山东医药,2016,56(28):93-95.
[2]相慧,韦真,邓庭军.无创呼吸机用于慢阻肺合并急性呼吸衰竭治疗的临床效果版[J].中华结核和呼吸杂志,2014,36(4):255-264．
[3]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订观察)[J].临床合理用药杂志,2016,9(4B):3-4．
[4]焦雪.阿替普酶联合低分子肝素钠溶栓治疗老年急性次大面积肺栓塞的疗效[J].中国老年学杂志, 2013,33(13):3062-3063.
[5]李阳.老年慢阻肺合并肺结核临床治疗效果观察研究[J].中国卫生标准管理,2015,6(2):163-164．

相似文献/References:

[1]王 伟,宫秀群,余 亮.阿替普酶治疗急性脑梗死患者临床转归的影响因素[J].医学信息,2022,35(11):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
　WANG Wei,GONG Xiu-qun,YU Liang.The Influencing Factors of Clinical Outcome in Patients with Acute Cerebral Infarction Treated with Alteplase[J].Medical Information,2022,35(05):84.[doi:10.3969/j.issn.1006-1959.2022.11.022]
[2]王新宇,刘光宇.华法林过量致自发性小肠壁内血肿的MSCT表现[J].医学信息,2018,31(21):161.[doi:10.3969/j.issn.1006-1959.2018.21.047]
　WANG Xinyu,LIU Guangyu.Spontaneous Intramural Hematoma of Small Bowel Secondary to Excessive Warfarin Therapy: MSCT Manifestations and Its Clinical Value[J].Medical Information,2018,31(05):161.[doi:10.3969/j.issn.1006-1959.2018.21.047]
[3]褚春沐.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的效果及对脑血管储备功能的影响[J].医学信息,2022,35(13):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
　CHU Chun-mu.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Medical Information,2022,35(05):133.[doi:10.3969/j.issn.1006-1959.2022.13.031]
[4]于德爱,宋会伟.阿替普酶急诊溶栓治疗超早期急性心肌梗死的疗效[J].医学信息,2020,33(10):157.[doi:10.3969/j.issn.1006-1959.2020.10.047]
　YU De-ai,SONG Hui-wei.The efficacy of Alteplase in Emergency Thrombolysis for Ultra-early Acute Myocardial Infarction[J].Medical Information,2020,33(05):157.[doi:10.3969/j.issn.1006-1959.2020.10.047]
[5]赵东慧.阿替普酶静脉溶栓联合氯吡格雷对急性脑梗死患者脑血流动力学及CRP、Hcy、HDL-C水平的影响[J].医学信息,2022,35(20):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
　ZHAO Dong-hui.Effect of Alteplase Intravenous Thrombolysis Combined with Clopidogrel on Cerebral Hemodynamics and Levels of CRP, Hcy and HDL-C in Patients with Acute Cerebral Infarction[J].Medical Information,2022,35(05):74.[doi:10.3969/j.issn.1006-1959.2022.20.018]
[6]王东旭.华法林抗凝治疗与CYP2C9基因多态性的研究[J].医学信息,2023,36(02):176.[doi:10.3969/j.issn.1006-1959.2023.02.039]
　WANG Dong-xu.Research in Warfarin Anticoagulant Treatment and Genetic Polymorphisms of CYP2C9[J].Medical Information,2023,36(05):176.[doi:10.3969/j.issn.1006-1959.2023.02.039]
[7]赵鑫龙,杨杰孚.华法林药物基因组学的应用[J].医学信息,2021,34(20):50.[doi:10.3969/j.issn.1006-1959.2021.20.012]
　ZHAO Xin-long,YANG Jie-fu.Application of Warfarin Pharmacogenomics[J].Medical Information,2021,34(05):50.[doi:10.3969/j.issn.1006-1959.2021.20.012]
[8]周 跃,高永超.阿替普酶早期静脉溶栓治疗急性脑梗塞对患者凝血功能、氧化炎症反应及神经功能的影响[J].医学信息,2022,35(03):156.[doi:10.3969/j.issn.1006-1959.2022.03.041]
　ZHOU Yue,GAO Yong-chao.Effect of Early Intravenous Thrombolysis with Alteplase on Coagulation Function,Oxidative Inflammatory Response and Neurological Function in Patients with Acute Cerebral Infarction[J].Medical Information,2022,35(05):156.[doi:10.3969/j.issn.1006-1959.2022.03.041]
[9]赵东慧,王 楠,杨思远.阿加曲班联合阿替普酶静脉溶栓治疗急性脑梗死的疗效及对脑血管储备功能的影响[J].医学信息,2023,36(13):151.[doi:10.3969/j.issn.1006-1959.2023.13.033]
　ZHAO Dong-hui,WANG Nan,YANG Si-yuan.Effect of Argatroban Combined with Alteplase Intravenous Thrombolysis on Acute Cerebral Infarction and its Effect on Cerebrovascular Reserve Function[J].Medical Information,2023,36(05):151.[doi:10.3969/j.issn.1006-1959.2023.13.033]
[10]赵东慧,王 楠,杨思远.不同阿替普酶溶栓时间对急性缺血性脑卒中患者神经功能及不良反应的影响[J].医学信息,2023,36(14):108.[doi:10.3969/j.issn.1006-1959.2023.14.021]
　ZHAO Dong-hui,WANG Nan,YANG Si-yuan.Effect of Different Alteplase Thrombolysis Time on Neurological Function and Adverse Reactions in Patients with Acute Ischemic Stroke[J].Medical Information,2023,36(05):108.[doi:10.3969/j.issn.1006-1959.2023.14.021]

更新日期/Last Update: 2019-03-01